Press Releases

Date Title and Summary
Toggle Summary Accuray to Present at Citi Investment Research Small & Mid-Cap Conference
SUNNYVALE, Calif., March 10 /PRNewswire-FirstCall/ -- Accuray Incorporated (Nasdaq: ARAY), a global leader in the field of radiosurgery, announced today that its management is scheduled to present at the Citi Investment Research Small & Mid-Cap Conference at the Four Seasons Hotel in Las Vegas on
Toggle Summary Accuray's CyberKnife System Receives 2008 North American Medical Devices Product of the Year Award From Frost & Sullivan
SUNNYVALE, Calif., March 12 /PRNewswire-FirstCall/ -- Accuray Incorporated (Nasdaq: ARAY), a global leader in the field of radiosurgery, announced today that the company received the 2008 North American Medical Devices Product of the Year award, from global growth consulting company Frost &
Toggle Summary CyberKnife Radiosurgery Used to Treat Lung Tumors at 90 Percent of Centers Worldwide
More Than 5,000 Lung Cancer Patients Treated With CyberKnife System to Date SUNNYVALE, Calif., March 26 /PRNewswire-FirstCall/ -- Accuray Incorporated (Nasdaq: ARAY), a global leader in the field of radiosurgery, announced today that approximately 90 percent of CyberKnife centers worldwide are now
Toggle Summary Accuray's CFO to Present at B. Riley & Company Ninth Annual Investor Conference
SUNNYVALE, Calif., March 27 /PRNewswire-FirstCall/ -- Accuray Incorporated (Nasdaq: ARAY), a global leader in the field of radiosurgery, announced today that its senior vice president and chief financial officer, Robert E. McNamara, is scheduled to present at the B.
Toggle Summary CyberKnife Prostate Cancer Planning Study Published in Leading Radiation Oncology Journal
Study Supports CyberKnife's Clinical Flexibility, Expanding Physicians Options for the Treatment of Prostate Cancer SUNNYVALE, Calif., April 8, 2008 /PRNewswire-FirstCall/ -- Accuray Incorporated (Nasdaq: ARAY), a global leader in the field of radiosurgery, announced today that a study published in
Toggle Summary First CyberKnife System Sold in Switzerland
Renowned Clinic Invests in Extracranial Radiosurgery SUNNYVALE, Calif., April 11 /PRNewswire-FirstCall/ -- Accuray Incorporated (Nasdaq: ARAY), a global leader in the field of radiosurgery, today announced that the Hirslanden Clinic in Zurich, part of the renowned Hirslanden group of private
Toggle Summary Accuray Incorporated to Report Third Quarter Fiscal Year 2008 Financial Results
SUNNYVALE, Calif, April 14 /PRNewswire-FirstCall/ -- Accuray Incorporated (Nasdaq: ARAY), a global leader in the field of radiosurgery, today announced that it will report results for its third quarter fiscal year 2008, ending March 29, 2008, on Tuesday, April 29, 2008 after the market closes.
Toggle Summary Accuray Incorporated's CEO to Present at Morgan Stanley 2008 Global Healthcare Unplugged Conference
SUNNYVALE, Calif., April 24 /PRNewswire-FirstCall/ -- Accuray Incorporated (Nasdaq: ARAY), a global leader in the field of radiosurgery, announced today that its president and chief executive officer, Euan S. Thomson, Ph.D., is scheduled to present at the Morgan Stanley 2008 Global Healthcare
Toggle Summary Accuray Reports Record Revenue in Third Quarter of Fiscal 2008
Click here for PDF version of this release Fourth Consecutive Quarter of Profitability SUNNYVALE, Calif., April 29 /PRNewswire-FirstCall/ -- Accuray Incorporated (Nasdaq: ARAY), a global leader in the field of radiosurgery, announced today financial results for the third quarter of fiscal 2008,
Toggle Summary Accuray Wins Innovations in Healthcare(SM) ABBY Award
Award from Adaptive Business Leaders (ABL) Organization Recognizes Companies with Transformative Advances in Healthcare SUNNYVALE, Calif., April 30 /PRNewswire-FirstCall/ -- Accuray Incorporated (Nasdaq: ARAY), a global leader in the field of radiosurgery, today announced that the company won the

*The quarterly and year-end results reported herein were subsequently revised for adjustments that were immaterial, individually and in the aggregate. The revised quarterly and year-end results are included in our Annual Report on Form 10-K, filed with the Securities and Exchange Commission (the "SEC") on August 25, 2020, and are accessible on our website at https://investors.accuray.com/financial-information/sec-filings and on the SEC's website at www.sec.gov.